DK1171140T3 - Behandling af overfölsomhedsreaktionslidelser - Google Patents

Behandling af overfölsomhedsreaktionslidelser

Info

Publication number
DK1171140T3
DK1171140T3 DK00922353T DK00922353T DK1171140T3 DK 1171140 T3 DK1171140 T3 DK 1171140T3 DK 00922353 T DK00922353 T DK 00922353T DK 00922353 T DK00922353 T DK 00922353T DK 1171140 T3 DK1171140 T3 DK 1171140T3
Authority
DK
Denmark
Prior art keywords
treatment
hypersensitivity reaction
aliquot
patient
reaction disorders
Prior art date
Application number
DK00922353T
Other languages
English (en)
Inventor
Anthony E Bolton
Daniel Sauder
Arkady Mandel
Original Assignee
Vasogen Ireland Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vasogen Ireland Ltd filed Critical Vasogen Ireland Ltd
Application granted granted Critical
Publication of DK1171140T3 publication Critical patent/DK1171140T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0023—Agression treatment or altering
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/40—Peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0004—Homeopathy; Vitalisation; Resonance; Dynamisation, e.g. esoteric applications; Oxygenation of blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3681—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by irradiation
    • A61M1/3683—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by irradiation using photoactive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3681—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by irradiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3687—Chemical treatment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/369—Temperature treatment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/02—Gases
    • A61M2202/0216—Ozone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/05—General characteristics of the apparatus combined with other kinds of therapy
    • A61M2205/051—General characteristics of the apparatus combined with other kinds of therapy with radiation therapy
    • A61M2205/053—General characteristics of the apparatus combined with other kinds of therapy with radiation therapy ultraviolet

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Vascular Medicine (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Anesthesiology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Chemical Or Physical Treatment Of Fibers (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK00922353T 1999-04-19 2000-04-19 Behandling af overfölsomhedsreaktionslidelser DK1171140T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CA 2269364 CA2269364A1 (en) 1999-04-19 1999-04-19 Treatment of inflammatory and allergic disorders
EP00922353A EP1171140B1 (en) 1999-04-19 2000-04-19 Treatment of hypersensitivity reaction disorders
PCT/CA2000/000433 WO2000062788A2 (en) 1999-04-19 2000-04-19 Treatment of hypersensitivity reaction disorders

Publications (1)

Publication Number Publication Date
DK1171140T3 true DK1171140T3 (da) 2004-10-25

Family

ID=4163470

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00922353T DK1171140T3 (da) 1999-04-19 2000-04-19 Behandling af overfölsomhedsreaktionslidelser

Country Status (10)

Country Link
EP (1) EP1171140B1 (da)
AT (1) ATE269096T1 (da)
AU (1) AU773577B2 (da)
CA (2) CA2269364A1 (da)
DE (1) DE60011598T2 (da)
DK (1) DK1171140T3 (da)
ES (1) ES2223503T3 (da)
NZ (1) NZ515173A (da)
PT (1) PT1171140E (da)
WO (1) WO2000062788A2 (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2271190A1 (en) 1999-05-06 2000-11-06 Vasogen Ireland Limited Improved method for treating mammals with modified mammalian blood
CA2308105A1 (en) * 2000-05-11 2001-11-11 Vasogen Ireland Limited Treatment of il-10 deficiencies
CA2309417A1 (en) 2000-05-25 2001-11-25 Anthony E. Bolton Apoptotic entities for use in treatment of endothelium dysfunction disorders
MXPA04004178A (es) * 2001-11-01 2004-09-06 Janssen Pharmaceutica Nv Heteroarilaminas como inhibidores de glucogeno cintasa cinasa 3beta.
WO2006007710A2 (en) * 2004-07-20 2006-01-26 Vasogen Ireland Limited Acute inflammatory condition treatment
CN115281154B (zh) * 2022-08-30 2023-11-03 中国人民解放军联勤保障部队第九〇四医院 一种伪无菌大鼠模型的构建方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5147289A (en) * 1990-03-29 1992-09-15 Therakos, Inc Non-specific immune system enhancement
US5980954A (en) * 1992-02-07 1999-11-09 Vasogen Ireland Limited Treatment of autoimmune diseases

Also Published As

Publication number Publication date
DE60011598T2 (de) 2005-07-14
AU773577B2 (en) 2004-05-27
EP1171140B1 (en) 2004-06-16
PT1171140E (pt) 2004-10-29
WO2000062788A2 (en) 2000-10-26
WO2000062788A3 (en) 2001-02-22
AU4278200A (en) 2000-11-02
CA2370453A1 (en) 2000-10-26
WO2000062788A9 (en) 2001-10-25
EP1171140A2 (en) 2002-01-16
CA2269364A1 (en) 2000-10-19
ES2223503T3 (es) 2005-03-01
ATE269096T1 (de) 2004-07-15
DE60011598D1 (de) 2004-07-22
NZ515173A (en) 2003-06-30

Similar Documents

Publication Publication Date Title
EA200401525A1 (ru) Способы лечения гепатита (варианты )
GB0226931D0 (en) Chemical compounds
MX349188B (es) Sns - 595 y metodos para utilizar el mismo.
ATE552014T1 (de) Sterilisationsverfahren mit wasserstoffperoxid und ozon
EA200500124A1 (ru) Способ и аппарат для введения в организм моноксида углерода
ATE281839T1 (de) Behandlung des kongestiven herzversagens durch vorbehandeltes autologes blut
RS110504A (en) Pharmaceutical use of nitric oxide, heme oxygenase-1 and products of heme degradation
IL164761A0 (en) Activated oxidizing vapor treatment system and method
WO2002058564A3 (en) Surgical articles
UA39975C2 (uk) Вакцина проти респіраторно-репродуктивного синдрому свиней
NO20073032L (no) Fremgangsmate for rensing av silisium samt silisium
DK2014293T3 (da) Anvendelse af argon i gasformig tilstand til at behandle neurointoxikation
DK1171140T3 (da) Behandling af overfölsomhedsreaktionslidelser
DE60018569D1 (de) Neue verwendung von hypoosmotischen salinelösungen und darauf basierendem medikament
AU4906400A (en) Low temperature plasma sterilising system and method
ZA200201408B (en) Use of docetaxel for treating hepatocellular carcinoma.
SG152045A1 (en) Method for treating an hiv-infected individual by combining immunization with structured interruption of anti-retroviral treatment
DE60232154D1 (de) Prophylaktische und therapeutische verwendung von hydroxysteroiden
ATE253922T1 (de) Behandlung von stress und vorbehandlng gegen stress
WO2003045428A3 (de) Verwendung einer technisch veränderten zelle als vakzine zur behandlung einer tumorerkrankung
WO2001022976A3 (en) Combination of a statin and ex-vivo treated blood for treating artheroclerosis
MD2872G2 (ro) Metodă de pronostic al riscului apariţiei hiperplaziei dishormonale a glandei mamare
FR2300047A1 (fr) Procede de traitement des eaux residuaires renfermant des composes organiques soufres
ATE288263T1 (de) Verwendung von n-oleoylethanolamin zur behandlung der schuppenflechte (psoriasis)
UA3797U (uk) Спосіб лікування тяжких проникаючих поранень ока